Colloid generation, stability, and transport are important processes that can significantly influence the fate and transport of nutrients and contaminants in environmental systems. Here, we critically review the existing literature on colloids in redox-dynamic environments and summarize the current state of knowledge regarding the mechanisms of colloid generation and the chemical controls over colloidal behavior in such environments. We also identify critical gaps, such as the lack of universally accepted cross-discipline definition and modeling infrastructure that hamper an in-depth understanding of colloid generation, behavior, and transport potential. We propose to go beyond a size-based operational definition of colloids and consider the functional differences between colloids and dissolved species. We argue that to predict colloidal transport in redox-dynamic environments, more empirical data are needed to parametrize and validate models. We propose that colloids are critical components of element budgets in redox-dynamic systems and must urgently be considered in field as well as lab experiments and reactive transport models. We intend to bring further clarity and openness in reporting colloidal measurements and fate to improve consistency. Additionally, we suggest a methodological toolbox for examining impacts of redox dynamics on colloids in field and lab experiments.

Retinal degeneration (RD) affects millions of people and is a major cause of ocular impairment and blindness. With a wide range of mutations and conditions leading to degeneration, targeting downstream processes is necessary for developing effective treatments. Ceramide and sphingosine-1-phosphate, a pair of bioactive sphingolipids, are involved in apoptosis and its prevention, respectively. Apoptotic cell death is a potential driver of RD, and in order to understand the mechanism of degeneration and potential treatments, we studied rhodopsin mutant RD model, P23H-1 rats. Investigating this genetic model of human RD allows us to investigate the association of sphingolipid metabolites with the degeneration of the retina in P23H-1 rats and the effects of a specific modulator of sphingolipid metabolism, FTY720. We found that P23H-1 rat retinas had altered sphingolipid profiles that, when treated with FTY720, were rebalanced closer to normal levels. FTY720-treated rats also showed protection from RD compared with their vehicle-treated littermates. Based on these data, we conclude that sphingolipid dysregulation plays a secondary role in retinal cell death, which may be common to many forms of RDs, and that the U.S. Food and Drug Administration-approved drug FTY720 or related compounds that modulate sphingolipid metabolism could potentially delay the cell death.